Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Psychopharmacology

• Publication date

  2002-01-31

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-001-0981-2PMID 11889500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems

  2004cited by this paper
• Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain

  2004cited by this paper
• Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats

  2004cited by this paper
• Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates

  2004cited by this paper
• Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system

  2004cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine.

  2001cited by this paper
• Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review

  2000cited by this paper
• Structure and function of dopamine receptors.

  2000cited by this paper
• Anatomical and pharmacological specificity of the rewarding effect elicited by microinjections of morphine into the nucleus accumbens of mice

  2000cited by this paper
• Opioids, reward and addiction: An encounter of biology, psychology, and medicine.

  1999cited by this paper
• Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies.

  1999cited by this paper
• Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.

  1999cited by this paper
• Functional heterogeneity in dopamine release and in the expression of Fos‐like proteins within the rat striatal complex

  1999cited by this paper
• Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens.

  1998influential reference
• The neurobiology of opiate reinforcement.

  1998cited by this paper
• Rewarding effects elicited by the microinjection of either AMPA or NMDA glutamatergic antagonists into the ventral tegmental area revealed by an intracranial self‐administration paradigm in mice

  1998cited by this paper
• Self-administration of the GABAA antagonist bicuculline into the ventral tegmental area in mice: dependence on D2 dopaminergic mechanisms

  1997cited by this paper
• Systemic Morphine-Induced Fos Protein in the Rat Striatum and Nucleus Accumbens Is Regulated by μ Opioid Receptors in the Substantia Nigra and Ventral Tegmental Area

  1997cited by this paper
• Self-infusion of GABA(A) antagonists directly into the ventral tegmental area and adjacent regions.

  1997cited by this paper
• The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites.

  1997cited by this paper
• μ-Opioid Receptors Are Localized to Extrasynaptic Plasma Membranes of GABAergic Neurons and Their Targets in the Rat Nucleus Accumbens

  1997cited by this paper
• Role of Dopamine D1 and D2 Receptors in the Nucleus Accumbens in Mediating Reward

  1997cited by this paper
• Deprivation State Switches the Neurobiological Substrates Mediating Opiate Reward in the Ventral Tegmental Area

  1997cited by this paper
• Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

  1997cited by this paper
• Role of Dopamine D 1 and D 2 Receptors in the Nucleus Accumbens in Mediating Reward

  1997cited by this paper
• Preference for self-administration of a low dose of morphine into the ventral tegmental area rather than into the amygdala in mice

  1996cited by this paper
• The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis.

  1995cited by this paper
• Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization.

  1995cited by this paper
• Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence

  1995cited by this paper
• Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self‐administration

  1995cited by this paper
• A comparative study of self-administration of morphine into the amygdala and the ventral tegmental area in mice.

  1994cited by this paper
• Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors.

  1994cited by this paper
• Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer

  1994cited by this paper
• Drug‐ and behavior‐associated changes in dopamine‐related electrochemical signals during intravenous heroin self‐administration in rats

  1993cited by this paper
• Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.

  1993cited by this paper
• Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.

  1993cited by this paper
• Opiate infusion into nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward.

  1992cited by this paper
• Opioids excite dopamine neurons by hyperpolarization of local interneurons

  1992cited by this paper
• Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study

  1992cited by this paper
• Interaction between Endogenous Opioids and Dopamine within the Nucleus Accumbens a

  1992cited by this paper
• Receptor subtypes in opioid and stimulant reward.

  1992cited by this paper
• Dopamine depletion produces augmented behavioral responses to a Mu‐, but not a delta‐opioid receptor agonist in the nucleus accumbens: Lack of a role for receptor upregulation

  1992cited by this paper
• Evidence for opiate-dopamine cross-sensitization in nucleus accumbens: studies of conditioned reward.

  1992cited by this paper
• Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study.

  1991cited by this paper
• Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens

  1991cited by this paper
• Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment.

  1991cited by this paper
• Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats.

  1991cited by this paper
• Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release.

  1991cited by this paper
• Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.

  1990cited by this paper
• Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat.

  1990cited by this paper
• The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study

  1990cited by this paper
• Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2‐d‐penicillamine, 5‐d‐penicillamine]enkephalin (125I‐DPDPE)

  1990cited by this paper
• Self-administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat.

  1989cited by this paper
• SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?

  1989cited by this paper
• Opiate influences on nucleus accumbens neuronal electrophysiology: dopamine and non-dopamine mechanisms

  1989cited by this paper
• Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions.

  1989cited by this paper
• Autoradiographic localization of μ-opioid and neurotensin receptors within the mesolimbic dopamine system

  1989cited by this paper
• A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior.

  1988cited by this paper
• Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists.

  1988cited by this paper
• Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

  1988cited by this paper
• Lack of an effect of 6-hydroxydopamine lesions of the nucleus accumbens on intravenous morphine self-administration.

  1988cited by this paper
• Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.

  1987cited by this paper
• Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats.

  1987cited by this paper
• Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.

  1987cited by this paper
• Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.

  1987cited by this paper
• Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens.

  1987cited by this paper
• Self-administration of morphine into the lateral hypothalamus in the mouse.

  1987cited by this paper
• Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release.

  1986cited by this paper
• Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.

  1985cited by this paper
• Effects of 6-OHDA lesions of the central medial nucleus accumbens on rat intravenous morphine self-administration.

  1985cited by this paper
• Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine.

  1984cited by this paper
• Morphine-induced activation of A10 dopamine neurons in the rat.

  1983cited by this paper
• Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.

  1983cited by this paper
• Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons.

  1983cited by this paper
• Reinforcing effects of morphine in the nucleus accumbens.

  1982cited by this paper
• Intracranial self-administration of morphine into the ventral tegmental area in rats.

  1981cited by this paper
• Heroin reward is dependent on a dopaminergic substrate.

  1981cited by this paper
• Reinforcing effects of morphine microinjection into the ventral tegmental area.

  1980cited by this paper
• Involvement of neurohypophyseal peptides in drug-mediated adaptive responses.

  1980cited by this paper
• Neuroanatomical focus for morphine and enkaphalin-induced hypermotility

  1977cited by this paper
• Separation of inhibiting and stimulating effects of morphine on self-stimulation behaviour by intracerebral microinjections.

  1976cited by this paper

• Can the incentive-sensitization theory of addiction incorporate addiction to opioid drugs?

  2026cites this paper
• Neural and Behavioral Dynamics of Acute Fentanyl Administration and Implications for Hazard Assessment of Novel Synthetic Opioids in Larval Zebrafish

  2025cites this paper
• Group singing and its effect on cortisol, alpha amylase, oxytocin, and pain threshold in patients with Parkinson's disease

  2025cites this paper
• Disruption of positive- and negative-feature morphine interoceptive occasion setters by dopamine receptor agonism and antagonism in male and female rats

  2024cites this paper
• Intermittent access to oxycodone decreases dopamine uptake in the nucleus accumbens core during abstinence

  2022cites this paper
• Regulation of Cocaine-related Behaviors by Estrogen and Progesterone.

  2022cites this paper
• Anterior insular-nucleus accumbens pathway controls refeeding-induced analgesia under chronic inflammatory pain condition.

  2021cites this paper
• 'Defrosting' music chills with naltrexone: The role of endogenous opioids for the intensity of musical pleasure.

  2021cites this paper
• On Musical Rewards: 'Defrosting' musical chills with Naltrexone

  2019cites this paper
• Involvement of the dopamine D1 receptor system in the anxiolytic effect of cedrol in the elevated plus maze and light-dark box tests.

  2019cites this paper
• Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone

  2017cites this paper
• Opioid‐induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons

  2017cites this paper
• Regional and source‐based patterns of [11C]‐(+)‐PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine‐use disorder

  2017cites this paper
• Ventral tegmental area glutamate neurons co-release GABA and promote positive reinforcement

  2016cites this paper
• Exposure to opiates in female adolescents alters mu opiate receptor expression and increases the rewarding effects of morphine in future offspring.

  2016cites this paper
• Behavioral studies on the role of opioid system in palatability and acquisition of reinforcement for dietary fat

  2015cites this paper
• The opioid system majorly contributes to preference for fat emulsions but not sucrose solutions in mice

  2015cites this paper
• Dopamine receptor D1 but not D3 essential for morphine-induced conditioned responses.

  2015cites this paper
• The opioid system contributes to the acquisition of reinforcement for dietary fat but is not required for its maintenance.

  2015cites this paper
• Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence

  2014cites this paper
• Translational Investigations of Rewarding Substances Using the Curve-Shift Method of Intracranial Self-Stimulation in Mice

  2014cites this paper
• Drug Abuse Takes a Toll: Toll-Like Receptor 4 Signaling is Required for the Rewarding and Reinforcing Effects of Opioids, Cocaine, and Methamphetamine

  2014cites this paper
• Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation

  2013cites this paper
• Involvement of Protein Degradation by the Ubiquitin Proteasome System in Opiate Addictive Behaviors

  2013cites this paper
• Methamphetamine Self-Administration: Neurochemical Consequences and Behavioural Effects

  2012cites this paper
• The rewarding and cognitive effects of corticosterone in mice

  2012cites this paper
• Mapping of reinforcing and analgesic effects of the mu opioid agonist Endomorphin-1 in the ventral midbrain of the rat

  2012cites this paper
• Effect of saikosaponin A on maintenance of intravenous morphine self-administration.

  2012cites this paper
• Disrupting Effect of Drug-Induced Reward on Spatial But Not Cue-Guided Learning: Implication of the Striatal Protein Kinase A/cAMP Response Element-Binding Protein Pathway

  2011cites this paper
• Unidirectional relationship between heroin self-administration and impulsive decision-making in rats

  2011cites this paper
• Mu Opioid Receptor Mediated Analgesia and Reward

  2011cites this paper
• The opioid systems--panacea and nemesis.

  2010cites this paper
• Dopamine Receptor Subtypes in Reward and Relapse

  2010cites this paper
• Reward processing by the opioid system in the brain.

  2009cites this paper
• Naltrexone in Smoking Cessation: A Review of the Literature and Future Directions

  2009cites this paper
• Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin.

  2009cites this paper
• Brain Regional Fos Expression Elicited by the Activation of μ- but not δ-Opioid Receptors of the Ventral Tegmental Area: Evidence for an Implication of the Ventral Thalamus in Opiate Reward

  2008cites this paper
• Anabolic-androgenic steroid dependence? Insights from animals and humans.

  2008influential citation
• Reinforcing effect for corn oil stimulus was concentration dependent in an operant task in mice.

  2007cites this paper
• Novel Pharmacologic Treatment of Stress and Addiction

  2007cites this paper
• Morphine self-administration into the lateral septum depends on dopaminergic mechanisms: Evidence from pharmacology and Fos neuroimaging.

  2007cites this paper
• Morphine-induced behavioral sensitization in alcohol-preferring and alcohol-avoiding rat lines

  2006cites this paper
• The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?

  2006cites this paper
• Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors.

  2006cites this paper
• Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway

  2006cites this paper
• Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.

  2006cites this paper
• Olanzapine antagonizes the acquisition and expression of morphine-induced conditioned place preference in male and female mice

  2006cites this paper
• Genetic dissociation of two behaviors associated with nicotine addiction: Beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome

  2006cites this paper
• Glucocorticoid receptor involvement in pair bonding in female prairie voles: the effects of acute blockade and interactions with central dopamine reward systems.

  2005cites this paper
• Dopamine Knockouts and Behavior

  2005cites this paper
• The effect of early psychostimulant treatment on abuse liability and dopamine receptors

  2005cites this paper
• Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice

  2005cites this paper
• Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors

  2005cites this paper
• Cocaine and heroin ('speedball') self-administration: the involvement of nucleus accumbens dopamine and mu-opiate, but not delta-opiate receptors.

  2005cites this paper
• Cocaine and heroin (‘speedball’) self-administration: the involvement of nucleus accumbens dopamine and μ-opiate, but not δ-opiate receptors

  2005cites this paper
• Ventral tegmental area involvement in pair bonding in male prairie voles.

  2005cites this paper
• Habituation to test procedure modulates the involvement of dopamine D2- but not D1-receptors in ethanol-induced locomotor stimulation in mice

  2005cites this paper
• Rewarding effects elicited by cocaine microinjections into the ventral tegmental area of C57BL/6 mice: involvement of dopamine D1 and serotonin1B receptors

  2004cites this paper
• Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists

  2004cites this paper
• Modulation of the discriminative stimulus effects of mu opioid agonists in rats: I. Effects of dopamine D2/3 antagonists

  2004cites this paper
• Reinforcing aspects of androgens.

  2004cites this paper
• Naltrexone attenuates acute cigarette smoking behavior.

  2004cites this paper
• Endogenous opiates and behavior: 2002.

  2003cites this paper
• The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice.

  2003cites this paper
• Morphine conditioned place preference is attenuated by perinatal lead exposure.

  2003cites this paper
• Differential behavioural sensitization to intermittent morphine treatment in alcohol‐preferring AA and alcohol‐avoiding ANA rats: role of mesolimbic dopamine

  2003cites this paper
• Brain reward circuitry: insights from unsensed incentives.

  2002cites this paper